Long term effect of gut microbiota transfer on diabetes development

Jian Peng, Sukanya Narasimhan, Julian R. Marchesi, Andrew Benson, F. Susan Wong, Li Wen

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

The composition of the gut microbiome represents a very important environmental factor that influences the development of type 1 diabetes (T1D). We have previously shown that MyD88-deficient non-obese diabetic (MyD88-/-NOD) mice, that were protected from T1D development, had a different composition of gut microbiota compared to wild type NOD mice. The aim of our study was to investigate whether this protection could be transferred. We demonstrate that transfer of gut microbiota from diabetes-protected MyD88-deficient NOD mice, reduced insulitis and significantly delayed the onset of diabetes. Gut bacteria from MyD88-deficient mice, administered over a 3-week period, starting at 4 weeks of age, stably altered the family composition of the gut microbiome, with principally Lachnospiraceae and Clostridiaceae increased and Lactobacillaceae decreased. The transferred mice had a higher concentration of IgA and TGFβ in the lumen that was accompanied by an increase in CD8+CD103+ and CD8αβ T cells in the lamina propria of the large intestine. These data indicate not only that gut bacterial composition can be altered after the neonatal/weaning period, but that the composition of the microbiome affects the mucosal immune system and can delay the development of autoimmune diabetes. This result has important implications for the development of probiotic treatment for T1D.

Original languageEnglish (US)
Pages (from-to)85-94
Number of pages10
JournalJournal of Autoimmunity
Volume53
Issue numberC
DOIs
StatePublished - Jan 1 2014

Fingerprint

Type 1 Diabetes Mellitus
Inbred NOD Mouse
Lactobacillaceae
Microbiota
Large Intestine
Probiotics
Weaning
Immunoglobulin A
Immune System
Mucous Membrane
Bacteria
T-Lymphocytes
Gastrointestinal Microbiome

Keywords

  • Gut microbiota
  • Innate immunity
  • Mucosal immunology
  • Type 1 diabetes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Long term effect of gut microbiota transfer on diabetes development. / Peng, Jian; Narasimhan, Sukanya; Marchesi, Julian R.; Benson, Andrew; Wong, F. Susan; Wen, Li.

In: Journal of Autoimmunity, Vol. 53, No. C, 01.01.2014, p. 85-94.

Research output: Contribution to journalArticle

Peng, Jian ; Narasimhan, Sukanya ; Marchesi, Julian R. ; Benson, Andrew ; Wong, F. Susan ; Wen, Li. / Long term effect of gut microbiota transfer on diabetes development. In: Journal of Autoimmunity. 2014 ; Vol. 53, No. C. pp. 85-94.
@article{c17524b1ac9746ebb8b007c383d3c2a6,
title = "Long term effect of gut microbiota transfer on diabetes development",
abstract = "The composition of the gut microbiome represents a very important environmental factor that influences the development of type 1 diabetes (T1D). We have previously shown that MyD88-deficient non-obese diabetic (MyD88-/-NOD) mice, that were protected from T1D development, had a different composition of gut microbiota compared to wild type NOD mice. The aim of our study was to investigate whether this protection could be transferred. We demonstrate that transfer of gut microbiota from diabetes-protected MyD88-deficient NOD mice, reduced insulitis and significantly delayed the onset of diabetes. Gut bacteria from MyD88-deficient mice, administered over a 3-week period, starting at 4 weeks of age, stably altered the family composition of the gut microbiome, with principally Lachnospiraceae and Clostridiaceae increased and Lactobacillaceae decreased. The transferred mice had a higher concentration of IgA and TGFβ in the lumen that was accompanied by an increase in CD8+CD103+ and CD8αβ T cells in the lamina propria of the large intestine. These data indicate not only that gut bacterial composition can be altered after the neonatal/weaning period, but that the composition of the microbiome affects the mucosal immune system and can delay the development of autoimmune diabetes. This result has important implications for the development of probiotic treatment for T1D.",
keywords = "Gut microbiota, Innate immunity, Mucosal immunology, Type 1 diabetes",
author = "Jian Peng and Sukanya Narasimhan and Marchesi, {Julian R.} and Andrew Benson and Wong, {F. Susan} and Li Wen",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.jaut.2014.03.005",
language = "English (US)",
volume = "53",
pages = "85--94",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "C",

}

TY - JOUR

T1 - Long term effect of gut microbiota transfer on diabetes development

AU - Peng, Jian

AU - Narasimhan, Sukanya

AU - Marchesi, Julian R.

AU - Benson, Andrew

AU - Wong, F. Susan

AU - Wen, Li

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The composition of the gut microbiome represents a very important environmental factor that influences the development of type 1 diabetes (T1D). We have previously shown that MyD88-deficient non-obese diabetic (MyD88-/-NOD) mice, that were protected from T1D development, had a different composition of gut microbiota compared to wild type NOD mice. The aim of our study was to investigate whether this protection could be transferred. We demonstrate that transfer of gut microbiota from diabetes-protected MyD88-deficient NOD mice, reduced insulitis and significantly delayed the onset of diabetes. Gut bacteria from MyD88-deficient mice, administered over a 3-week period, starting at 4 weeks of age, stably altered the family composition of the gut microbiome, with principally Lachnospiraceae and Clostridiaceae increased and Lactobacillaceae decreased. The transferred mice had a higher concentration of IgA and TGFβ in the lumen that was accompanied by an increase in CD8+CD103+ and CD8αβ T cells in the lamina propria of the large intestine. These data indicate not only that gut bacterial composition can be altered after the neonatal/weaning period, but that the composition of the microbiome affects the mucosal immune system and can delay the development of autoimmune diabetes. This result has important implications for the development of probiotic treatment for T1D.

AB - The composition of the gut microbiome represents a very important environmental factor that influences the development of type 1 diabetes (T1D). We have previously shown that MyD88-deficient non-obese diabetic (MyD88-/-NOD) mice, that were protected from T1D development, had a different composition of gut microbiota compared to wild type NOD mice. The aim of our study was to investigate whether this protection could be transferred. We demonstrate that transfer of gut microbiota from diabetes-protected MyD88-deficient NOD mice, reduced insulitis and significantly delayed the onset of diabetes. Gut bacteria from MyD88-deficient mice, administered over a 3-week period, starting at 4 weeks of age, stably altered the family composition of the gut microbiome, with principally Lachnospiraceae and Clostridiaceae increased and Lactobacillaceae decreased. The transferred mice had a higher concentration of IgA and TGFβ in the lumen that was accompanied by an increase in CD8+CD103+ and CD8αβ T cells in the lamina propria of the large intestine. These data indicate not only that gut bacterial composition can be altered after the neonatal/weaning period, but that the composition of the microbiome affects the mucosal immune system and can delay the development of autoimmune diabetes. This result has important implications for the development of probiotic treatment for T1D.

KW - Gut microbiota

KW - Innate immunity

KW - Mucosal immunology

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84926417712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926417712&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2014.03.005

DO - 10.1016/j.jaut.2014.03.005

M3 - Article

C2 - 24767831

AN - SCOPUS:84926417712

VL - 53

SP - 85

EP - 94

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - C

ER -